#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Atypical haemolytic uraemic syndrome Systemic lupus erythematosus Infantile apnoea High-grade B-cell lymphoma Malignant glioma Adult T-cell lymphoma/leukaemia refractory Vascular malformation Measles Autoinflammation with infantile enterocolitis Systemic scleroderma Glomerulonephritis membranoproliferative Hypergammaglobulinaemia benign monoclonal Congenital megacolon Transitional cell carcinoma Ovarian cancer More trials…

    Learn about Rare Diseases

    Mastocytosis Congenital nephrogenic diabetes insipidus Castleman’s disease – Diagnostics Medulloblastoma – Basic Information Synovial sarcoma recurrent Progressive supranuclear palsy – Basic Information Fragile X syndrome – Treatment Castleman’s disease – Life with Disease CADASIL Rett syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zinc Acetate Dihydrate Neflamapimod Exidavnemab Allopurinol Metronidazole Allo-647 Amikacin Sulfate Linezolid Fidanacogene Elaparvovec Fosfomycin Bedaquiline Arsenic Trioxide Fluasterone Roflumilast Palonosetron Hydrochloride Specific Nucleic Acid Sna-Her2 Cabazitaxel Regn7075 Valganciclovir Sodium Iodide (123 I) More therapies…

    Learn about Your Condition

    Diminished ovarian reserve Progressive multiple sclerosis Thrombocytosis Alcoholism Polycystic liver disease Gouty arthritis Femur fracture Atrophic vulvovaginitis Basal cell carcinoma Pustular psoriasis Rectal cancer Myotonia Porphyria non-acute Intracranial calcification Neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary embolism

  • Study of Catheter-Directed Thrombolysis Using Alteplase for Treatment of Intermediate-High Risk Acute Pulmonary Embolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Alteplase
    Czechia

  • Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Deep vein thrombosis postoperative
    • Pelvic venous thrombosis
    Investigated Drugs:
    • Rosuvastatin Calcium
    France Norway

  • Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Oxygen
    Italy Spain

  • Study on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Drugs:
    • Rivaroxaban
    Belgium France The Netherlands

  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Heparin Calcium
    • D,L-Lysine Acetylsalicylate
    France

  • Study on Treatments for Intermediate High-Risk Pulmonary Embolism: Comparing Percutaneous Embolectomy, Ultrasound-Assisted Thrombolysis with Alteplase, and Heparin

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alteplase
    • Heparin
    • Tinzaparin Sodium
    Denmark
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!